Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

EG665149 Inhibitors

EG665149 inhibitors represent a class of chemical compounds known primarily for their ability to interfere with specific molecular pathways within cells. These inhibitors function by targeting proteins or enzymes associated with the regulation of signaling pathways, particularly those involved in cellular proliferation and survival. Structurally, the inhibitors are characterized by their unique scaffold, which allows them to bind selectively to their target proteins, typically through competitive inhibition at the active site or an allosteric site. The chemical composition often includes aromatic rings, heterocyclic cores, and various functional groups like amides, esters, or halogen substituents, contributing to their binding affinity and specificity. The molecular design of EG665149 inhibitors is crafted to optimize interactions with the target's binding pocket, often guided by structural biology techniques, such as X-ray crystallography or computational modeling, to enhance binding efficacy and stability.

The binding of EG665149 inhibitors to their targets induces conformational changes or inhibits key enzymatic activities, leading to a disruption of downstream signaling cascades. This mechanism of action can have profound effects on cellular behavior, influencing processes like gene expression, apoptosis, and cell cycle progression. The inhibitors are often tested for their specificity and potency against a range of cellular targets to refine their chemical structure for better efficacy. Additionally, their solubility, permeability, and stability are critical factors in their design to ensure they maintain functionality under various biological conditions. The development and study of EG665149 inhibitors contribute to understanding cellular pathways and mechanisms that are fundamental to molecular biology, making them valuable tools for biochemical research and molecular pathway elucidation.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interacts with DNA and inhibits RNA synthesis, which can affect the transcription of Sox5os5.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

Inhibits RNA polymerase II, potentially reducing the expression of Sox5os5.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

Inhibits transcription elongation by RNA polymerase II, which can decrease Sox5os5 levels.

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Inhibits the transcription of a broad range of genes, which may include Sox5os5.

Quinacrine, Dihydrochloride

69-05-6sc-204222
sc-204222B
sc-204222A
sc-204222C
sc-204222D
100 mg
1 g
5 g
200 g
300 g
$46.00
$57.00
$87.00
$3257.00
$4821.00
4
(2)

Binds to DNA and can alter transcription, potentially affecting Sox5os5 expression.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Inhibits RNA synthesis by terminating RNA chain elongation, which might affect Sox5os5 levels.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Inhibits nuclear export of RNA, which could impact the localization and function of Sox5os5.

CX-5461

1138549-36-6sc-507275
5 mg
$245.00
(0)

Inhibits RNA polymerase I, and might indirectly affect Sox5os5 expression by altering cellular transcriptional landscape.

(+)-Irinotecan

97682-44-5sc-269253
10 mg
$62.00
1
(1)

Inhibits topoisomerase I, leading to DNA damage and potential downstream effects on Sox5os5 expression.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$51.00
$231.00
$523.00
63
(1)

Inhibits topoisomerase II, causing DNA damage and potentially affecting Sox5os5 expression.